Myozyme and respiratory failure Patient Reports February 12, 2012

Myozyme Side Effects Report #5859264-X
Myozyme side effect was reported by a Health Professional from NETHERLANDS on Aug 15, 2008. Male patient, 77 years of age, weighting 156.5 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac failure, decubitus ulcer, myocardial infarction, respiratory failure. Myozyme dosage: 20 MG/KG, QOW, INTRAVENOUS. Patient was hospitalized. Patient died on 08/09/2008.

Myozyme Side Effects Report #5873523-6
Myozyme side effect was reported by a Physician from NETHERLANDS on Aug 15, 2008. Male patient, 77 years of age, weighting 156.5 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac failure, decubitus ulcer, myocardial infarction, respiratory failure. Myozyme dosage: 20 MG/KG, QOW, INTRAVENOUS. Patient was hospitalized. Patient died on 08/09/2008.

Myozyme Side Effects Report #5372071-X
Myozyme side effect was reported by a Physician from FRANCE on June 11, 2007. Female patient, 72 years of age, weighting 132.3 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: lung infection, respiratory failure, staphylococcal infection

, superinfection. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with CARDENSIEL. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5680877-2
Myozyme side effect was reported by a Health Professional from UNITED STATES on Mar 15, 2008. Female patient, 72 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: asthenia, bedridden, decreased appetite, respiratory failure. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient died on 12/13/2007.

Myozyme Side Effects Report #5585850-0
Myozyme side effect was reported by a Physician from FRANCE on Dec 14, 2007. Male patient, 69 years of age, weighting 141.1 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, respiratory failure. Myozyme dosage: 1380 MG, Q2W, INTRAVENOUS. During the same period patient was treated with AMOIR, TRANDOLAPRIL, DEBRIDAT, LACTULOSE. Patient died on 10/02/2007.

Myozyme Side Effects Report #5677968-9
Myozyme side effect was reported by a Physician from UNITED STATES on Mar 05, 2008. Male patient, 69 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: pneumonia

, respiratory failure. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient died on 12/16/2007.

Myozyme Side Effects Report #5369681-2
Myozyme side effect was reported by a Physician from FRANCE on June 07, 2007. Male patient, 57 years of age, weighting 216.1 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: condition aggravated, fatigue, lung infection, pulmonary congestion, respiratory failure. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with MUCOMYST. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5547337-0
Myozyme side effect was reported by a Physician from AUSTRALIA on Nov 22, 2007. Female patient, 47 years of age, weighting 121.3 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: acquired diaphragmatic eventration, bronchiectasis, pneumothorax, pulmonary fibrosis

, red blood cell sedimentation rate increased, respiratory failure. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA, ESOMEPRAZOLE, CITALOPRAM HYDROBROMIDE, OXYBUTYNIN CHLORIDE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5567550-6
Myozyme side effect was reported by a Physician from AUSTRALIA on Dec 05, 2007. Female patient, 47 years of age, weighting 121.3 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood ph increased, bronchiectasis, dyspnoea, pco2 decreased, pneumothorax, po2 increased, pulmonary fibrosis

, respiratory failure. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA, ESOMEPRAZOLE, CITALOPRAM HYDROBROMIDE, OXYBUTYNIN CHLORIDE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5603318-X
Myozyme side effect was reported by a Physician from AUSTRALIA on Jan 08, 2008. Female patient, 47 years of age, weighting 121.3 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: acquired diaphragmatic eventration, blood ph increased, bronchiectasis, lung injury, pleural fibrosis, pneumothorax, respiratory failure, urinary tract infection

. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with ESOMEPRAZOLE, CITALOPRAM HYDROBROMIDE, OXYBUTYNIN CHLORIDE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5233630-8
Myozyme side effect was reported by a Physician from BRAZIL on Jan 24, 2007. Male patient, 46 years of age, weighting 165.3 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: respiratory failure. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient died on 01/19/2007.

Myozyme Side Effects Report #5262288-7
Myozyme side effect was reported by a Physician from BRAZIL on Feb 23, 2007. Male patient, 46 years of age, weighting 165.3 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, respiratory failure. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient died on 01/19/2007.

Myozyme Side Effects Report #5326886-4
Myozyme side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Apr 28, 2007. Female patient, child 4 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac arrest

, cyanosis, device malfunction, respiratory failure. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA. Patient died on 04/28/2007.

Myozyme Side Effects Report #5692867-4
Myozyme side effect was reported by a Physician from ITALY on Mar 19, 2008. Male patient, 39 years of age, weighting 94.80 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac failure, haemothorax, pneumothorax, pyrexia, respiratory failure, sepsis

. Myozyme dosage: 20 MG/KG, INTRAVENOUS. During the same period patient was treated with ANTIBIOTICS. Patient died on 12/06/2007.

Myozyme Side Effects Report #5947746-1
Myozyme side effect was reported by a Physician from FRANCE on Oct 29, 2008. Male patient, 38 years of age, weighting 194.0 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: condition aggravated, confusional state, delusion, mental disorder, respiratory failure. Myozyme dosage: 20 MG/KG, Q2W; INTRAVENOUS. During the same period patient was treated with RISPERDAL. Patient was hospitalized. Patient died.

Myozyme Side Effects Report #5887098-9
Myozyme side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Sept 03, 2008. Female patient, child 3 years of age, weighting 24.03 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bradycardia, cardiac arrest

, hypoxia, impaired gastric emptying, nausea

, occult blood positive, respiratory failure, upper gastrointestinal haemorrhage. Myozyme dosage: 138 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5930994-4
Myozyme side effect was reported by a Physician from ALGERIA on Oct 13, 2008. Male patient, 28 years of age, weighting 97.00 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bacterial infection

, lung disorder, mechanical ventilation complication, respiratory failure. Myozyme dosage: 20 MG/KG, QOW, INTRAVENOUS. During the same period patient was treated with IMIPENEM, LOVENOX. Patient died on 07/20/2008.

Myozyme Side Effects Report #5735807-1
Myozyme side effect was reported by a Physician from UNITED STATES on May 06, 2008. Female patient, child 2 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: asthenia, pneumonia

, respiratory failure. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient died on 04/25/2008.

Myozyme Side Effects Report #5738427-8
Myozyme side effect was reported by a Physician from UNITED STATES on Apr 30, 2008. Male patient, child 2 years of age, weighting 30.86 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: disease progression, hypokinesia, muscular weakness, nystagmus, respiratory failure. Myozyme dosage: unknown. During the same period patient was treated with ASPIRIN, COREG, LASIX, ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE, RANITIDINE. Patient recovered.

Myozyme Side Effects Report #5861841-7
Myozyme side effect was reported by a Physician from TURKEY on Aug 08, 2008. Female patient, child 12 years of age, weighting 53.79 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: platelet count increased, post procedural haemorrhage, pulmonary haemorrhage, respiratory failure. Myozyme dosage: 550 MG, QOW, INTRAVENOUS. During the same period patient was treated with CAPTOPRIL, PROZAC, ISOSORBIDE MONONITRATE, ATARAX, SUCRALFATE, ACETYLCYSTEINE. Patient died on 08/07/2008.

Myozyme Side Effects Report #5330165-9
Myozyme side effect was reported by a Physician from UNITED STATES on May 02, 2007. Male patient, child 1 years of age, weighting 22.05 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: disease recurrence, muscular weakness, respiratory failure. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5398771-3
Myozyme side effect was reported by a Physician from FRANCE on July 12, 2007. Male patient, child 1 years of age, weighting 22.71 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: pneumonia aspiration, respiratory failure. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5425042-9
Myozyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 03, 2007. Male patient, child 1 years of age, weighting 28.66 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: pneumonia

, respiratory distress, respiratory failure. Myozyme dosage: unknown. During the same period patient was treated with ALPHA. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5513552-5
Myozyme side effect was reported by a Physician from SAUDI ARABIA on Oct 25, 2007. Male patient, child 1 years of age, weighting 13.23 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: diastolic dysfunction, infection

, respiratory failure. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with VANCOMYCIN, CEFTAZIDIME. Patient was hospitalized and became disabled. Patient recovered.

Myozyme Side Effects Report #5564699-9
Myozyme side effect was reported by a Physician from FRANCE on Nov 30, 2007. Male patient, child 1 years of age, weighting 26.46 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: anoxia, cardio-respiratory arrest, catheter related infection, convulsion, hypotonia, respiratory failure, salivary hypersecretion, secretion discharge, staphylococcal infection

. Myozyme dosage: 30 MG/KG 12WKS IV. During the same period patient was treated with RENITEC, FORTUM, PHOSPHONEUROS. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5567346-5
Myozyme side effect was reported by a Physician from SAUDI ARABIA on Dec 11, 2007. Male patient, child 1 years of age, weighting 13.23 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: diastolic dysfunction, infection

, respiratory failure. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with VANCOMYCIN, CEFTAZIDIME. Patient was hospitalized and became disabled. Patient recovered.

Myozyme Side Effects Report #5247439-2
Myozyme side effect was reported by a Physician from UNITED STATES on Feb 06, 2007. Female patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiomyopathy

, condition aggravated, pneumonia

, respiratory failure, tracheitis. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5254709-0
Myozyme side effect was reported by a Physician from UNITED STATES on Feb 12, 2007. Female patient, weighting 21.16 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: asthenia, cardiac failure, condition aggravated, respiratory failure, urinary tract infection

. Myozyme dosage: 200 MG Q2WKS IV. During the same period patient was treated with LASIX, CAPTOPRIL, COREG. Patient was hospitalized. Patient died on 02/15/2007.

Myozyme Side Effects Report #5264301-X
Myozyme side effect was reported by a Physician from ITALY on Feb 23, 2007. Female patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: respiratory failure, respiratory tract infection viral. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5298945-6
Myozyme side effect was reported by a Physician from UNITED STATES on Mar 28, 2007. Female patient, weighting 21.16 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bradycardia, cardiac failure, cardio-respiratory arrest, pneumonia

, respiratory failure, urinary tract infection

. Myozyme dosage: 200 MG Q2WKS IV. During the same period patient was treated with LASIX, CAPTOPRIL, COREG. Patient was hospitalized. Patient died on 02/15/2007.

Myozyme Side Effects Report #5331027-3
Myozyme side effect was reported by a Physician from FRANCE on May 03, 2007. Male patient, weighting 16.31 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: respiratory failure. Myozyme dosage: 150 MG Q2WKS IV. During the same period patient was treated with KREDEX. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5362841-6
Myozyme side effect was reported by a Physician from UNITED STATES on June 01, 2007. Male patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: base excess increased, blood bicarbonate increased, muscle disorder

, oxygen saturation decreased, pyrexia, respiratory failure, wheezing. Myozyme dosage: 10 MG/KG QWK IV. During the same period patient was treated with DIGOXIN. Patient died on 06/07/2007.

Myozyme Side Effects Report #5362893-3
Myozyme side effect was reported by a Physician from UNITED STATES on June 01, 2007. Male patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: influenza, left ventricular hypertrophy, muscular weakness, pneumonia aspiration, respiratory failure, respiratory tract infection viral, upper respiratory tract infection. Myozyme dosage: 150 MG Q2WKS IV. During the same period patient was treated with LASIX, ENALAPRIL, XOPENEX, PULMICORT, PREVACID. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5362975-6
Myozyme side effect was reported by a Physician from FRANCE on June 04, 2007. Male patient, weighting 18.96 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: respiratory failure, salivary hypersecretion, weight increased. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with KREDEX. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5094039-3
Myozyme side effect was reported by a Physician from SPAIN on Aug 18, 2006. Male patient, weighting 18.08 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cyanosis, respiratory arrest, respiratory failure, urticaria. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with FUROSEMIDE, HYDROCHLOROTHIAZIDE, CARVEDILOL. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5106347-8
Myozyme side effect was reported by a Physician from SPAIN on Aug 30, 2006. Male patient, weighting 18.08 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: nasopharyngitis, respiratory arrest, respiratory failure, urticaria. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with FUROSEMIDE, HYDOCHLOROTHIAZIDE, CARVEDILOL. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5159354-3
Myozyme side effect was reported by a Physician from SPAIN on Nov 06, 2006. Male patient, weighting 18.08 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cyanosis, dyspnoea, respiratory arrest, respiratory failure, urticaria. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with FUROSEMIDE, HYDROCHLOROTHIAZIDE, CARVEDILOL. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5404196-4
Myozyme side effect was reported by a Physician from UNITED STATES on July 17, 2007. Male patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood gases abnormal, cardio-respiratory arrest, oxygen saturation decreased, pneumonia aspiration, respiratory distress, respiratory failure. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient was hospitalized. Patient died on 07/19/2007.

Myozyme Side Effects Report #5490291-0
Myozyme side effect was reported by a Health Professional from UNITED STATES on Oct 03, 2007. Male patient, weighting 13.85 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac arrest

, cough, fluid overload, hepatomegaly, respiratory failure, wheezing. Myozyme dosage: 50 MG ONCE IV. During the same period patient was treated with FENTANYL, PROPRANOLOL, PULMICORT, BUDESONIDE, MIRLAX, TIMENTIN. Patient was hospitalized. Patient died on 08/22/2007.

Myozyme Side Effects Report #5534675-0
Myozyme side effect was reported by a Physician from UNITED STATES on Nov 16, 2007. Male patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: aspiration, catheter related infection, cleft palate, disease progression, disease recurrence, dysphagia, nystagmus, respiratory failure. Myozyme dosage: 40 MG/KG Q2WKS IV. During the same period patient was treated with RITUXIMAB, METHOTREXATE, IMMUNE GLOBULIN INTRAVENOUS, BENADRYL, TYLENOL. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5586084-6
Myozyme side effect was reported by a Health Professional from UNITED STATES on Dec 27, 2007. Female patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bradycardia, cardiac arrest

. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient died on 12/21/2007.

Myozyme Side Effects Report #5663917-6
Myozyme side effect was reported by a Physician from UNITED KINGDOM on Feb 26, 2008. Male patient, weighting 26.24 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: pneumonia aspiration, respiratory failure, respiratory tract infection viral. Myozyme dosage: 240 MG, Q2W, INTRAVENOUS. Patient died on 02/28/2008.

Myozyme Side Effects Report #5688181-3
Myozyme side effect was reported by a Physician from BELGIUM on Mar 13, 2008. Female patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: condition aggravated, glycogen storage disease type ii, muscular weakness, respiratory failure. Myozyme dosage: unknown. Patient died on 12/21/2007.

Myozyme Side Effects Report #5689669-1
Myozyme side effect was reported by a Physician from SPAIN on Mar 13, 2008. Male patient, weighting 27.56 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: anaphylactic reaction, bronchospasm, cardiac failure, cyanosis, infusion related reaction, nasopharyngitis, respiratory arrest, respiratory failure, transaminases increased. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS; 40 MG/KG, Q2W, INTRAVENOUS; 20 MG/KG, Q2W, INTRAVENOUS. Patient died on 02/01/2008.

Myozyme Side Effects Report #5706591-2
Myozyme side effect was reported by a Health Professional from UNITED STATES on Apr 02, 2008. Female patient, weighting 18.30 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac disorder, respiratory failure, respiratory tract infection. Myozyme dosage: unknown. Patient was hospitalized. Patient died on 03/12/2008.

Myozyme Side Effects Report #5722743-X
Myozyme side effect was reported by a Physician from UNITED STATES on Apr 11, 2008. Male patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: collapse of lung, gastroenteritis viral, pneumonia aspiration, respiratory failure. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5751836-6
Myozyme side effect was reported by a Physician from UNITED STATES on May 15, 2008. Female patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: collapse of lung, gastroenteritis viral, pneumonia aspiration, respiratory failure. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5735451-6
Myozyme side effect was reported by a Physician from UNITED STATES on Apr 29, 2008. Male patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: collapse of lung, gastroenteritis viral, pneumonia aspiration, respiratory failure. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5735454-1
Myozyme side effect was reported by a Physician from UNITED STATES on Apr 29, 2008. Male patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood immunoglobulin g abnormal, collapse of lung, gastroenteritis viral, pneumonia aspiration, respiratory failure. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5753736-4
Myozyme side effect was reported by a Physician from SPAIN on May 13, 2008. Female patient, weighting 27.56 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: anaphylactic reaction, cardiac failure, respiratory arrest, respiratory failure. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS; 40 MG/KG,Q2W, INTRAVENOUS. Patient died on 02/01/2008.

Myozyme Side Effects Report #5759052-9
Myozyme side effect was reported by a Physician from SPAIN on Mar 13, 2008. Male patient, weighting 27.56 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: anaphylactic reaction, cardiac failure, infusion related reaction, nasopharyngitis, respiratory arrest, respiratory failure, respiratory tract infection. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS; 40 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with ACTOCORTINA, SPIRONOLACTONE, CARVEDILOL. Patient died on 02/01/2008.

Myozyme Side Effects Report #5761737-5
Myozyme side effect was reported by a Consumer or non-health professional from UNITED STATES on May 19, 2008. Female patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: respiratory failure. Myozyme dosage: 20 MG/KG, ONCE, INTRAVENOUS. Patient died on 05/15/2008.

Myozyme Side Effects Report #5765883-1
Myozyme side effect was reported by a Physician from UNITED STATES on May 23, 2008. Male patient, weighting 17.42 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: collapse of lung, gastroenteritis viral, pneumonia aspiration, respiratory failure. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5776177-2
Myozyme side effect was reported by a Consumer or non-health professional from UNITED STATES on June 05, 2008. Female patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiomyopathy

, carnitine deficiency, respiratory failure. Myozyme dosage: 20 MG/KG, ONCE, INTRAVENOUS. Patient died on 05/14/2008.

Myozyme Side Effects Report #5777231-1
Myozyme side effect was reported by a Consumer or non-health professional from UNITED STATES on June 05, 2008. Female patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiomyopathy

, carnitine deficiency, respiratory failure. Myozyme dosage: 20 MG/KG, ONCE, INTRAVENOUS. Patient died on 05/14/2008.

Myozyme Side Effects Report #5824169-7
Myozyme side effect was reported by a Physician from UNITED KINGDOM on July 09, 2008. Male patient, weighting 26.24 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: pneumonia aspiration, respiratory failure, respiratory tract infection viral, therapeutic response decreased. Myozyme dosage: 240 MG, Q2W, INTRAVENOUS. Patient died on 02/28/2008.

Myozyme Side Effects Report #5839280-4
Myozyme side effect was reported by a Physician from FRANCE on July 22, 2008. Female patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, hypertension, pyrexia, respiratory failure. Myozyme dosage: 150 MG, Q4W, INTRAVENOUS, 100 MG, Q4W, INTRAVENOUS. Patient was hospitalized. Patient died on 07/25/2008.

Myozyme Side Effects Report #5851864-6
Myozyme side effect was reported by a Physician from FRANCE on Aug 05, 2008. Female patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, hypertension, pyrexia, respiratory failure. Myozyme dosage: 150 MG, Q4W, INTRAVENOUS; 100 MG Q4W INTRAVENOUS. During the same period patient was treated with FUROSEMIDE. Patient was hospitalized. Patient died on 07/25/2008.

Myozyme Side Effects Report #5871621-4
Myozyme side effect was reported by a Physician from UNITED KINGDOM on Aug 19, 2008. Male patient, weighting 12.13 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: congestive cardiomyopathy, respiratory failure, respiratory tract infection. Myozyme dosage: 100 MG, Q2W, INTRAVENOUS 20 MG/KG, QW, INTRAVENOUS. During the same period patient was treated with DESLORATADINE, ASPIRIN, CAPTOPRIL, CARVEDILOL, FUROSEMIDE. Patient recovered.

Myozyme Side Effects Report #5888718-5
Myozyme side effect was reported by a Physician from UNITED KINGDOM on Sept 08, 2008. Male patient, weighting 12.13 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: antibody test positive, congestive cardiomyopathy, muscular weakness, respiratory failure, respiratory tract infection. Myozyme dosage: 100 MG Q2W INTRAVENOUS; 100 MG Q2W INTRAVENOUS; 20 MG/KG QW INTRAVENOUS. During the same period patient was treated with DESLORATADINE, ASPIRIN, CAPTOPRIL, CARVEDILOL, FUROSEMIDE. Patient recovered.

Myozyme Side Effects Report #5909538-9
Myozyme side effect was reported by a Physician from JAPAN on Sept 18, 2008. Female patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: aspiration, dysphagia, respiratory disorder, respiratory failure, respiratory syncytial virus infection

. Myozyme dosage: unknown. Patient recovered.

Myozyme Side Effects Report #5912760-9
Myozyme side effect was reported by a Physician from UNITED KINGDOM on Sept 29, 2008. Male patient, weighting 12.13 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: congestive cardiomyopathy, infusion related reaction, muscular weakness, respiratory failure, respiratory tract infection. Myozyme dosage: 100 MG, Q2W, INTRAVENOUS; 20 MG/KG, QW, INTRAVENOUS. During the same period patient was treated with DESLORATADINE, ASPIRIN, CAPTOPRIL, CARVEDILOL, FUROSEMIDE. Patient recovered.

Myozyme Side Effects Report #5924753-6
Myozyme side effect was reported by a Health Professional from UNITED STATES on Oct 03, 2008. Female patient, weighting 15.87 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: dehydration, respiratory failure. Myozyme dosage: 150 MG, Q2W, INTRAVENOUS . Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5927527-5
Myozyme side effect was reported by a Physician from UNITED STATES on Oct 07, 2008. Male patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac failure, disease progression, nasopharyngitis, refusal of treatment by relative, respiratory failure. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient died on 10/07/2008.

Myozyme Side Effects Report #5945735-4
Myozyme side effect was reported by a Physician from UNITED KINGDOM on Oct 31, 2008. Male patient, weighting 12.13 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood immunoglobulin g increased, congestive cardiomyopathy, malaise, muscular weakness, respiratory failure, respiratory tract infection. Myozyme dosage: 100 MG, Q2W, INTRAVENOUS; 100 MG, Q2W, INTRAVENOUS; 20 MG/KG, QW, INTRAVENOUS. During the same period patient was treated with DESLORATADINE, ASPIRIN, CAPTOPRIL, CARVEDILOL, FUROSEMIDE. Patient recovered.

Myozyme Side Effects Report #5962710-4
Myozyme side effect was reported by a Health Professional from UNITED STATES on Nov 07, 2008. Female patient, weighting 15.87 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: dehydration, respiratory failure, weaning failure. Myozyme dosage: 150 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #5976517-5
Myozyme side effect was reported by a Physician from UNITED KINGDOM on Nov 11, 2008. Male patient, weighting 12.13 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: congestive cardiomyopathy, muscular weakness, respiratory failure, respiratory tract infection. Myozyme dosage: 100 MG, Q2W, INTRAVENOUS; 100 MG, Q2W, INTRAVENOUS; 20 MG/KG, QW, INTRAVENOUS. During the same period patient was treated with DESLORATADINE, ASPIRIN, CAPTORIL, CARVEDILOL, FUROSEMIDE. Patient died on 11/05/2008.

Myozyme Side Effects Report #5977683-8
Myozyme side effect was reported by a Health Professional from UNITED STATES on Nov 19, 2008. Female patient, weighting 17.86 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cellulitis

, dehydration, pneumonia

, respiratory failure. Myozyme dosage: 40 MG/KG, Q2W, INTRAVENOUS; 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with PULMICORT, XOPENEX, LASIX, FLOVENT, RANITIDINE. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #6015137-3
Myozyme side effect was reported by a Health Professional from UNITED STATES on Dec 05, 2008. Female patient, weighting 17.86 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cellulitis

, dehydration, medical device complication, pneumonia

, respiratory failure, tachypnoea. Myozyme dosage: 40 MG/KG, Q2W, INTRAVENOUS; 20 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with PULMICORT, XOPENEX, LASIX, FLOVENT, RANITIDINE. Patient was hospitalized. Patient recovered.

Myozyme Side Effects Report #6043378-8
Myozyme side effect was reported by a Physician from UNITED STATES on Jan 07, 2009. Female patient, weighting 11.46 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac arrest

, respiratory failure. Myozyme dosage: 100 MG, Q2W, INTRAVENOUS. During the same period patient was treated with NYSTATIN, LASIX, OXYGEN. Patient died on 01/06/2009.

Myozyme Side Effects Report #6055090-X
Myozyme side effect was reported by a Physician from CANADA on Jan 12, 2009. Male patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: respiratory failure. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient died on 01/09/2009.

Myozyme Side Effects Report #6057977-0
Myozyme side effect was reported by a Health Professional from UNITED STATES on Jan 22, 2009. Female patient, weighting 11.46 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: apnoea, asthenia, cardiac arrest

, respiratory failure. Myozyme dosage: 100 MG, Q2W, INTRAVENOUS. During the same period patient was treated with NYSTATIN, LASIX. Patient died on 01/06/2009.

Myozyme Side Effects Report #6081147-3
Myozyme side effect was reported by a Physician from UNITED KINGDOM on Feb 05, 2009. Male patient, weighting 21.16 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: antibody test positive, respiratory failure, sepsis

. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient recovered.

Myozyme Side Effects Report #6111292-5
Myozyme side effect was reported by a Physician from UNITED KINGDOM on Mar 02, 2009. Male patient, weighting 21.16 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: antibody test positive, respiratory failure, sepsis

. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient recovered.

Myozyme Side Effects Report #6051173-9
Myozyme side effect was reported by a Consumer or non-health professional from CANADA on Jan 12, 2009. Male patient was treated with Myozyme. After drug was administered, patient experienced the following side effects: respiratory failure. Myozyme dosage: 20 MG/KG, Q2W, INTRAVENOUS. Patient died on 01/09/2009.

Myozyme Side Effects Report #6130555-0
Myozyme side effect was reported by a Health Professional from UNITED STATES on Mar 09, 2009. Female patient, weighting 16.76 lb, was diagnosed with cardiomyopathy

and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiomyopathy

, pyrexia, respiratory failure. Myozyme dosage: 150 MG, QW, INTRAVENOUS. During the same period patient was treated with MILRINONE. Patient was hospitalized. Patient recovered.

Myozyme and respiratory failure

SideEffects101.com

Myozyme and respiratory failure Patient Reports February 12, 2012

side effects of Myozyme